We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Invitrogen Launches Antigen Immobilization Technology for Sensitive Immunoassays
Product News

Invitrogen Launches Antigen Immobilization Technology for Sensitive Immunoassays

Invitrogen Launches Antigen Immobilization Technology for Sensitive Immunoassays
Product News

Invitrogen Launches Antigen Immobilization Technology for Sensitive Immunoassays


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Invitrogen Launches Antigen Immobilization Technology for Sensitive Immunoassays"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Invitrogen Corporation has announced the launch of Dynabeads® M-270 Immunoassay (Carboxyl) from Dynal® – developed to provide immobilization of antigens such as proteins, peptides, steroids and hormones for in vitro diagnostic (IVD) magnetic bead-based immunoassay applications.

The antigens are coupled directly or via a cross-linker to carboxylic acid groups on the new 2.8 micron Dynabeads®. The hydrophilic surface of the beads ensures low non-specific binding of serum proteins that would otherwise interfere with the assay.

The beads disperse well, are easily handled in a wide variety of buffers and do not inhibit enzymatic activity.  Dynabeads® M-270 Immunoassay (Carboxyl) can also be included directly in downstream analysis of the bead-bound target molecule.

Advertisement